Jim Simons Mesoblast LTD Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$4.2 - $15.45 $893,159 - $3.29 Million	-212,657 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$3.38 - $10.63 $490,738 - $1.54 Million	145,189 Added 215.2%	212,657 $931,000
Q4 2019 Feb 13, 2020	SELL	$5.74 - $7.42 $23,023 - $29,761	-4,011 Reduced 5.61%	67,468 $497,000
Q3 2019 Nov 13, 2019	SELL	$4.68 - $7.42 $95,434 - $151,308	-20,392 Reduced 22.2%	71,479 $495,000
Q2 2019 Aug 12, 2019	SELL	$4.67 - $5.88 $160,783 - $202,442	-34,429 Reduced 27.26%	91,871 $488,000
Q1 2019 May 14, 2019	BUY	$4.19 - $5.25 $257,685 - $322,875	61,500 Added 94.91%	126,300 $663,000
Q4 2018 Feb 13, 2019	BUY	$3.51 - $8.6 $227,448 - $557,280	64,800 New	64,800 $267,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.69B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.